Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1978;5(Suppl 1):49S–51S.

Attempt to demonstrate an in vivo effect of mianserin hydrochloride on erythrocyte Na+-K+-ATPase activity and cyclic AMP concentration

G S Naylor, D E Buckley, L J Boardman, A H W Smith, J P Moody
PMCID: PMC1429210  PMID: 203308

Abstract

1 There is evidence that erythrocyte Na+-K+-ATPase activity and erythrocyte cyclic AMP change on recovery from a depressive illness. Mianserin is a recently introduced antidepressant but its mode of action is unknown. The present study was therefore designed to investigate in vivo the effect of mianserin on erythrocyte Na+-K+-ATPase and cyclic AMP.

2 Biochemical estimations were made on blood from depressed patients before beginning either mianserin or matched placebo treatment, after 1 week, and again after 2 weeks' treatment.

3 Neither the erythrocyte Na+-K+-ATPase, nor the erythrocyte cyclic AMP concentration, changed significantly in either the mianserin- or the placebo-treated group.

4 The study sheds no light on the possible mechanism of action of mianserin.

Full text

PDF
49S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdulla Y. H., Hamadah K. 3',5' cyclic adenosine monophosphate in depression and mania. Lancet. 1970 Feb 21;1(7643):378–381. doi: 10.1016/s0140-6736(70)91514-x. [DOI] [PubMed] [Google Scholar]
  2. Brown B. L., Albano J. D., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971 Feb;121(3):561–562. doi: 10.1042/bj1210561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. COPPEN A. J. Abnormality of the blood-cerebrospinal fluid barrier of patients suffering from a depressive illness. J Neurol Neurosurg Psychiatry. 1960 May;23:156–161. doi: 10.1136/jnnp.23.2.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Glen A. I., Ongley G. C., Robinson K. Diminished membrane transport in manic-depressive psychosis and recurrent depression. Lancet. 1968 Aug 3;2(7562):241–243. doi: 10.1016/s0140-6736(68)92351-9. [DOI] [PubMed] [Google Scholar]
  5. Naylor G. J., Dick D. A., Dick E. G. Erythrocyte membrane cation carrier, relapse rate of manic-depressive illness and response to lithium. Psychol Med. 1976 May;6(2):257–263. doi: 10.1017/s0033291700013805. [DOI] [PubMed] [Google Scholar]
  6. Naylor G. J., Dick D. A., Dick E. G., Le Poidevin D., Whyte S. F. Erythrocyte membrane cation carrier in depressive illness. Psychol Med. 1973 Nov;3(4):502–508. doi: 10.1017/s0033291700054313. [DOI] [PubMed] [Google Scholar]
  7. Robison G. A., Coppen A. J., Whybrow P. C., Prange A. J. Cyclic A.M.P. in affective disorders. Lancet. 1970 Nov 14;2(7681):1028–1029. doi: 10.1016/s0140-6736(70)92835-7. [DOI] [PubMed] [Google Scholar]
  8. Smith A. H., Naylor G. S., Moody J. P. Placebo-controlled double-blind trial of mianserin hydrochloride. Br J Clin Pharmacol. 1978;5 (Suppl 1):67S–70S. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES